{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:48:32Z","timestamp":1790704112420,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2017,3,15]]},"DOI":"10.5664\/jcsm.6500","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T15:39:17Z","timestamp":1489505957000},"page":"441-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Michel","family":"Lecendreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Corny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bourdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Delclaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"1303013_CR1","volume-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2005","unstructured":"American Academy of Sleep Medicine. International Classification of Sleep Disorders. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.","edition":"2nd"},{"key":"1303013_CR2","volume-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.","edition":"3rd"},{"issue":"7","key":"1303013_CR3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cns.12105","volume":"19","author":"CO Inocente","year":"2013","unstructured":"Inocente CO, Lavault S, Lecendreux M et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013;19(7):521\u2013528.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"1303013_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.sleep.2013.08.798","volume":"15","author":"CO Inocente","year":"2014","unstructured":"Inocente CO, Gustin M-P, Lavault S et al. Depressive feelings in children with narcolepsy. Sleep Med. 2014;15(3):309\u2013314.","journal-title":"Sleep Med"},{"issue":"8","key":"1303013_CR5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.5665\/sleep.4910","volume":"38","author":"M Lecendreux","year":"2015","unstructured":"Lecendreux M, Lavault S, Lopez R et al. Attention-deficit\/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: a cross-sectional study. Sleep. 2015;38(8):1285\u20131295.","journal-title":"Sleep"},{"issue":"8","key":"1303013_CR6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12291","volume":"20","author":"CO Inocente","year":"2014","unstructured":"Inocente CO, Gustin MP, Lavault S et al. Quality of life in children with narcolepsy. CNS Neurosci Ther. 2014;20(8):763\u2013771.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"1303013_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/000992280604500409","volume":"45","author":"D Hayes","year":"2006","unstructured":"Hayes D. Narcolepsy with cataplexy in early childhood. Clin Pediatr (Phila). 2006;45(4):361\u2013363.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"1303013_CR8","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2006-0647","volume":"118","author":"G Stores","year":"2006","unstructured":"Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics. 2006;118(4):e1116-e1123.","journal-title":"Pediatrics"},{"key":"1303013_CR9","first-page":"51","volume":"7","author":"DR Wozniak","year":"2015","unstructured":"Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep. 2015;7:51\u201361.","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"1303013_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","volume":"120","author":"V Cvetkovic-Lopes","year":"2010","unstructured":"Cvetkovic-Lopes V, Bayer L, Dorsaz S et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest. 2010;120(3):713\u2013719.","journal-title":"J Clin Invest"},{"issue":"7","key":"1303013_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","volume":"33","author":"M Kawashima","year":"2010","unstructured":"Kawashima M, Lin L, Tanaka S et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep. 2010;33(7):869\u2013874.","journal-title":"Sleep"},{"issue":"7","key":"1303013_CR12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","volume":"33","author":"H Toyoda","year":"2010","unstructured":"Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep. 2010;33(7):875\u2013878.","journal-title":"Sleep"},{"issue":"Pt 8","key":"1303013_CR13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","volume":"136","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Arnulf I, Lecendreux M et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain. 2013;136(Pt 8):2486\u20132496.","journal-title":"Brain"},{"issue":"3","key":"1303013_CR14","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","volume":"7","author":"M Partinen","year":"2012","unstructured":"Partinen M, Saarenpaa-Heikkila O, Ilveskoski I et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7(3):e33723.","journal-title":"PLoS One"},{"issue":"3","key":"1303013_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han F, Lin L, Warby SC et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol. 2011;70(3):410\u2013417.","journal-title":"Ann Neurol"},{"issue":"9","key":"1303013_CR16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","volume":"14","author":"MS Heier","year":"2013","unstructured":"Heier MS, Gautvik KM, Wannag E et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013;14(9):867\u2013871.","journal-title":"Sleep Med"},{"issue":"294","key":"1303013_CR17","doi-asserted-by":"crossref","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Volkmuth W, Duca J et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med. 2015;7(294):294ra105.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1303013_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.20892","volume":"60","author":"Y Dauvilliers","year":"2006","unstructured":"Dauvilliers Y. Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol. 2006;60(1):153.","journal-title":"Ann Neurol"},{"issue":"6","key":"1303013_CR19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","volume":"56","author":"Y Dauvilliers","year":"2004","unstructured":"Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56(6):905\u2013908.","journal-title":"Ann Neurol"},{"issue":"4","key":"1303013_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","volume":"12","author":"M Lecendreux","year":"2003","unstructured":"Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res. 2003;12(4):347\u2013348.","journal-title":"J Sleep Res"},{"issue":"10","key":"1303013_CR21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00415-008-0983-7","volume":"255","author":"G Plazzi","year":"2008","unstructured":"Plazzi G, Poli F, Franceschini C et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol. 2008;255(10):1549\u20131554.","journal-title":"J Neurol"},{"issue":"12","key":"1303013_CR22","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00415-008-0996-2","volume":"255","author":"PO Valko","year":"2008","unstructured":"Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol. 2008;255(12):1900\u20131903.","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"1303013_CR23","first-page":"828","volume":"13","author":"SM Zuberi","year":"2014","unstructured":"Zuberi SM, Mignot E, Ling L, McArthur I. Variable response to intravenous immunoglobulin therapy in childhood narcolepsy [Abstracts of the ESRS, Prague 2004]. J Sleep Res. 2014;13(Suppl 1):828.","journal-title":"J Sleep Res"},{"issue":"3","key":"1303013_CR24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.20603","volume":"58","author":"W Chen","year":"2005","unstructured":"Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol. 2005;58(3):489\u2013490.","journal-title":"Ann Neurol"},{"issue":"1","key":"1303013_CR25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","volume":"79","author":"S Knudsen","year":"2012","unstructured":"Knudsen S, Biering-Sorensen B, Kornum BR et al. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency. Neurology. 2012;79(1):102\u2013103.","journal-title":"Neurology"},{"issue":"4","key":"1303013_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2869.2011.00985.x","volume":"21","author":"CE Donjacour","year":"2011","unstructured":"Donjacour CE, Lammers GJ A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy. J Sleep Res. 2011;21(4):479\u2013480.","journal-title":"J Sleep Res"},{"issue":"3","key":"1303013_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/imt.14.7","volume":"6","author":"CM Hersh","year":"2014","unstructured":"Hersh CM, Cohen JA. Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis. Immunotherapy. 2014;6(3):249\u2013259.","journal-title":"Immunotherapy"},{"key":"1303013_CR28","first-page":"CD002063","volume":"9","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014;9:CD002063.","journal-title":"Cochrane Database Syst Rev"},{"key":"1303013_CR29","doi-asserted-by":"crossref","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003(4):CD004000.","DOI":"10.1002\/14651858.CD004000"},{"issue":"1","key":"1303013_CR30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/ijd.12423","volume":"54","author":"SJ Barron","year":"2014","unstructured":"Barron SJ, Del Vecchio MT, Aronoff SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol. 2014;54(1):108\u2013115.","journal-title":"Int J Dermatol"},{"issue":"7244","key":"1303013_CR31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240\u20131243.","journal-title":"BMJ"},{"issue":"5\u20136","key":"1303013_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/17477166.2011.607458","volume":"6","author":"MF Rolland-Cachera","year":"2011","unstructured":"Rolland-Cachera MF. Childhood obesity: current definitions and recommendations for their use. Int J Pediatr Obes. 2011;6(5\u20136):325\u2013331.","journal-title":"Int J Pediatr Obes"},{"issue":"1","key":"1303013_CR33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2869.1994.tb00104.x","volume":"3","author":"C Hublin","year":"1994","unstructured":"Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K. The Ullanlinna narcolepsy scale: validation of a measure of symptoms in the narcoleptic syndrome. J Sleep Res. 1994;3(1):52\u201359.","journal-title":"J Sleep Res"},{"issue":"4","key":"1303013_CR34","first-page":"455","volume":"26","author":"C Drake","year":"2003","unstructured":"Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep. 2003;26(4):455\u2013458.","journal-title":"Sleep"},{"issue":"7","key":"1303013_CR35","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"issue":"13","key":"1303013_CR36","first-page":"1","volume":"20","author":"A Olmos","year":"2015","unstructured":"Olmos A, Govindasamy P A practical guide for using propensity score weighting in R. Practical Assessment, Research & Evaluation. 2015;20(13):1\u20138.","journal-title":"Practical Assessment, Research & Evaluation"},{"issue":"2","key":"1303013_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3414\/ME0478","volume":"47","author":"Z Guo","year":"2008","unstructured":"Guo Z, Gill TM, Allore HG. Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons. Methods Inf Med. 2008;47(2):107\u2013116.","journal-title":"Methods Inf Med"},{"issue":"Pt 12","key":"1303013_CR38","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/brain\/awt277","volume":"136","author":"F Pizza","year":"2013","unstructured":"Pizza F, Franceschini C, Peltola H et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain. 2013;136(Pt 12):3787\u20133795.","journal-title":"Brain"},{"issue":"11","key":"1303013_CR39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/sleep\/33.11.1428","volume":"33","author":"Y Dauvilliers","year":"2010","unstructured":"Dauvilliers Y, Montplaisir J, Cochen V et al. Post-H1N1 narcolepsy-cataplexy. Sleep. 2010;33(11):1428\u20131430.","journal-title":"Sleep"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.6500\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/ViewAbstract.aspx?pid=30969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.6500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:17:59Z","timestamp":1770365879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.6500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3,15]]}},"alternative-id":["1303013"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.6500","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]},"assertion":[{"value":"11 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}